Korean Tranexamic Acid for Melasma and Dark Spots: The Evidence

Tranexamic acid keeps showing up on the ingredient lists of Korean brightening serums, usually paired with niacinamide and marketed at dark spots and melasma. It started life as a prescription drug for heavy bleeding, and dermatologists noticed by accident that patients taking it also saw their melasma fade. This article walks through what the ingredient actually does, how strong the evidence is for the topical serums you can buy, and where the honest limits are.

What Tranexamic Acid Is

Tranexamic acid (often shortened to TXA or TA on labels) is a synthetic version of the amino acid lysine. Its original and still primary medical job is to slow down bleeding. It does this by blocking plasmin, an enzyme that breaks down blood clots. In 2009 the U.S. Food and Drug Administration approved an oral form, sold as Lysteda, for heavy menstrual bleeding. That is the only FDA-approved use.

Every use of tranexamic acid for melasma and dark spots — oral, topical, or injected — is off-label. That does not mean it doesn't work. It means no regulator has formally reviewed and approved it for pigment, so the quality control and dosing standards that come with an approved indication aren't there. Keep that framing in mind for the rest of this article.

The melasma connection was discovered the way a lot of dermatology is discovered: by watching patients. People taking oral tranexamic acid for other reasons came back with lighter melasma. Researchers worked backward from there to figure out why.

How It Works on Pigment

Skin makes its brown pigment, melanin, inside cells called melanocytes. The enzyme that drives that production is tyrosinase. In melasma, melanocytes are overactive and the skin around them keeps sending "make more pigment" signals, often triggered by sun and hormones.

Tranexamic acid interrupts that signaling. The mechanism is reasonably well mapped out:

It blocks plasmin in keratinocytes (the most common skin cell). Plasmin normally helps release arachidonic acid, which leads to prostaglandins and other inflammatory messengers that tell melanocytes to ramp up.
With plasmin throttled, fewer of those messengers reach the melanocyte, so tyrosinase activity drops and less melanin gets made.
It also appears to calm the tiny blood vessels feeding melasma patches and to reduce some of the vascular and inflammatory drivers behind the condition.

The short version: tranexamic acid doesn't bleach existing pigment the way hydroquinone does. It turns down the volume on the signals that keep telling the skin to make new pigment. That is why most dermatologists treat it as a tool for the cause of melasma rather than a fast eraser of spots. A 2016 mechanism review in Clinical and Experimental Dermatology laid out this plasmin-tyrosinase pathway as the leading explanation for the topical effect.

The Evidence, Graded Honestly

This is where it matters to separate the three delivery routes, because they do not have the same level of support.

Oral tranexamic acid: the strongest evidence

The best data is for the pill, which you cannot get over the counter and which is not what's in your serum. It's worth covering because it's the benchmark everything else gets compared against.

A 2016 retrospective analysis in the Journal of the American Academy of Dermatology tracked 561 melasma patients treated with low-dose oral tranexamic acid. The majority — 503 patients, or 89.7% — improved, and response usually showed up within two months. That's a striking real-world number. But it came with a catch: among those who improved, 27.2% relapsed. And one patient developed a deep vein thrombosis (a blood clot) and had to stop; she was later found to have an inherited clotting disorder. Overall, 7.1% of patients had some adverse event, most of them minor and temporary.

A 2024 systematic review and meta-analysis in the Journal of Dermatological Treatment, covering 22 studies and 1,280 patients, found tranexamic acid significantly lowered melasma severity scores across the board. It also concluded that the oral route produced the largest reductions, followed by injections, with topical last. So when researchers rank the routes, the serum sits at the bottom of the effectiveness ladder — not because it fails, but because the pill simply delivers more drug to where it's needed.

Topical tranexamic acid: moderate, mixed evidence

This is the category your Korean serum falls into, so it deserves the most scrutiny.

The single most-cited topical trial is a 2012 double-blind randomized controlled trial in Asians, published in the Journal of Cosmetic and Laser Therapy. It tested topical 5% tranexamic acid and found it could improve melasma. That study is frequently quoted as proof the topical works. The honest reading is more cautious: results across topical trials are inconsistent, and a few well-run studies have found that a tranexamic acid product performed no better than its own vehicle (the base cream without the active). Penetration is the core problem — getting enough of the molecule down to the melanocytes through intact skin is hard.

Where topical TXA looks better is head-to-head against hydroquinone, the long-standing gold standard. A 2018 prospective randomized study compared topical 5% tranexamic acid solution against 3% hydroquinone cream in 100 melasma patients over 12 weeks. Both cut melasma severity by almost the same amount — the tranexamic acid group's MASI score dropped about 27%, the hydroquinone group about 26.7%, with no meaningful difference between them. The tranexamic acid group had far fewer side effects (6% irritation versus 20% erythema and 18% irritation for hydroquinone) and reported higher satisfaction.

So topical tranexamic acid lands at roughly "as good as a moderate hydroquinone, with fewer side effects" in the better trials — but the body of evidence is uneven, the doses studied (often 5%) are higher than many cosmetic serums use, and a research-grade solution is not the same as a marketed serum.

Injected tranexamic acid: a sidebar, not a serum

You'll see this route in dermatology clinics, delivered by microneedling or tiny intradermal injections (sometimes called mesotherapy). It matters here only as a benchmark: in the 2024 meta-analysis, injected tranexamic acid outperformed the topical route and trailed the oral pill. That ranking makes sense — a needle bypasses the skin barrier that limits how much serum reaches the melanocytes.

It's not something you do at home, and it's not what's in your bottle. But it explains the gap in your favor when you read about "tranexamic acid working great" — a lot of those headlines are built on oral or injected data, then quietly applied to serums. The serum is the gentlest, lowest-dose, lowest-penetration version of the molecule. Keep that translation in mind every time you see a bold claim.

Combination serums: where most Korean products live

Almost no Korean serum is tranexamic acid alone. They stack it with niacinamide, arbutin, vitamin C, and other brighteners. There's reasonable evidence this combination approach works.

A 2025 study compared a serum containing 5% niacinamide, 1% tranexamic acid, 0.2% stabilized vitamin C, and 1.5% glycolic acid against 4% hydroquinone in 60 women with melasma. After five months, the multi-ingredient serum cut MASI by 5.7 points versus 5.4 for hydroquinone — basically a tie — and patients overwhelmingly preferred the serum for hydration and feel (96.6% versus 73.3% acceptability). The relevant detail for shoppers: the tranexamic acid in that winning serum was only 1%, the lifting was shared with niacinamide and an exfoliating acid, and it took five months. That's the realistic profile of a Korean brightening serum.

Evidence summary table

Delivery route	Evidence strength	What good trials show	Honest caveat
Oral (pill)	Strongest	~90% improved in a 561-patient series; largest severity drops in meta-analysis	Prescription only; ~27% relapse; rare clot risk
Topical (serum)	Moderate, mixed	Matched 3% hydroquinone in a 100-person RCT, fewer side effects	Some trials show no benefit over vehicle; penetration is limited
Injected (microneedling/mesotherapy)	Moderate	Beat topical in pooled data	In-office only; needles; not a home serum
Combination serums	Moderate	Niacinamide + 1% TXA matched 4% hydroquinone over 5 months	Slow; effect shared across ingredients

What the Research Still Can't Tell Us

It's easy to read a string of positive studies and assume the question is settled. It isn't, and an honest evidence article has to say so plainly.

First, the topical trials are heterogeneous — that's the polite research word for "all over the place." They use different concentrations (3%, 5%, sometimes 10%), different bases, different durations, and different ways of scoring melasma. The 2024 meta-analysis flagged "high heterogeneity," especially in combination treatments. When studies disagree this much in their design, pooling them into one clean number gets shaky.

Second, the vehicle problem is real. A few of the better-controlled topical studies found that the tranexamic acid product didn't clearly beat the same product without the active. That points to a hard truth: getting enough of this molecule through intact skin and down to the melanocytes is genuinely difficult, and some of the improvement people see may come from the moisturizing base, the sunscreen they're told to use, or simple time.

Third, there's almost no good long-term data on cosmetic serums specifically. We know the oral pill relapses in over a quarter of responders. We don't have clean numbers on how long a serum's gains last after you stop, partly because most people don't stop — they just keep using it.

Fourth, dosing isn't standardized. Nobody has nailed down the minimum effective topical concentration, how often to apply, or for how long. The researchers themselves keep asking for standardized protocols. So when a serum lists "tranexamic acid" without a percentage, you genuinely cannot tell from the label whether it's at a researched dose or a token amount for marketing.

None of this means the serums are useless. It means the right posture is cautious optimism, not certainty.

What a Korean TXA Serum Realistically Does

Set expectations correctly and you'll be happier. A Korean tranexamic acid serum is a slow, gentle, low-risk option for fading melasma and post-inflammatory dark spots. The realistic outcome is gradual lightening over 8 to 20 weeks, with the best results when you're also rigorous about sunscreen.

What it is not: a fast spot eraser, a hydroquinone replacement for severe melasma, or a one-and-done fix. Melasma is chronic. Even the powerful oral form relapses in over a quarter of responders once stopped. A topical serum is something you keep using as maintenance, not a course you finish.

The doses in cosmetic serums also run lower than the research-grade products. Trials often use 3% to 5% tranexamic acid; popular Korean serums commonly land around 2% to 5%, frequently paired with niacinamide doing some of the heavy lifting. Higher isn't automatically better for tolerability, but it's worth knowing the strongest topical evidence used 5%.

Tranexamic Acid vs Other Brighteners

No single brightener wins for everyone. Here's how tranexamic acid stacks up against the ingredients it usually sits next to or competes with.

Ingredient	Best at	Evidence for pigment	Irritation risk	Notes
Tranexamic acid	Melasma, recurring discoloration	Moderate (topical), strong (oral)	Low	Targets the signal, not existing pigment
Hydroquinone	Fast, aggressive lightening	Strong, long-established	Moderate to high	Prescription in many places; not for indefinite use
Niacinamide	General brightening, barrier, oil	Moderate	Very low	Common TXA partner; broad benefits
Vitamin C	Antioxidant brightening, dullness	Moderate	Low to moderate	Stability and formulation matter a lot
Arbutin	Gentle even-toning	Limited but plausible	Low	A natural hydroquinone relative

Tranexamic acid's edge is the melasma signal pathway and its gentleness. If your concern is melasma specifically, or pigment that keeps coming back, it's a logical pick. If you want maximum speed and your dermatologist is supervising, hydroquinone still hits harder. Many people use them in sequence — hydroquinone to clear, then tranexamic acid and niacinamide to maintain.

For a deeper look at how these brighteners compare within the K-beauty world, see our guide to the best Korean ingredient for hyperpigmentation and the broader Korean hyperpigmentation brightening layer guide.

Safety and Side Effects

For the topical serum, the safety picture is reassuring. The most common issues are mild and local: slight irritation, dryness, or redness, reported in a small minority of users. In the head-to-head trial above, topical tranexamic acid caused noticeably fewer reactions than hydroquinone. There's no meaningful systemic clot risk from a serum, because almost none of it gets into your bloodstream through intact skin.

The clotting concern applies to the oral pill, not your serum, but it's worth understanding the line. Oral tranexamic acid is generally avoided in anyone with a history of blood clots, stroke, certain clotting disorders, or who is on estrogen-containing birth control without medical guidance. The 561-patient series had exactly one clot, in someone with an inherited clotting disorder. If a dermatologist ever puts you on the pill, that screening conversation is the important part.

For the serum, the standard sensible rules apply: patch test first, introduce it slowly, and pair it with daily sunscreen. Sun exposure is the single biggest driver of melasma, and any brightener works against an active sun trigger. A good Korean sunscreen does more for melasma than any serum — see our Korean sunscreens ingredient safety guide.

Who It's For

Tranexamic acid serums make the most sense for:

People with melasma — the symmetric brown patches on cheeks, forehead, or upper lip, often hormone-driven.
People with stubborn or recurring discoloration that comes back after other treatments fade it.
People with sensitive skin who can't tolerate hydroquinone or strong acids and want a gentle long-term option.
People who already use niacinamide and want to add a complementary, melasma-targeted active.

It's a weaker pick if you want fast, dramatic lightening of deep pigment, or if your "dark spots" are actually freckles, sun spots, or texture (those respond better to other approaches). And if your melasma is severe or spreading, see a dermatologist — the oral form or in-office treatments may be a faster path, and a serum alone may underdeliver.

If you're building a full routine around brightening, our Korean glass skin ingredient stack covers how to layer actives without overloading the skin.

How to Use It

Apply a tranexamic acid serum once or twice daily to clean, dry skin, before heavier creams. It layers well with niacinamide (they're often in the same product) and with hyaluronic acid. Be cautious stacking it with strong exfoliating acids or retinoids in the same step if your skin is reactive — alternate them or use them at different times of day.

Give it time. Pigment turns over slowly. Most trials run 8 to 12 weeks minimum before judging results, and the combination-serum study took five months to fully separate from baseline. Daily broad-spectrum sunscreen isn't optional here; without it you're refilling the tub while you drain it.

The Bottom Line

Tranexamic acid is a genuinely interesting brightener with a solid mechanism and a real track record — most of it earned by the oral prescription form. The topical serums you can buy, including Korean ones, sit on moderate and somewhat mixed evidence: in the better trials they match a moderate hydroquinone with fewer side effects, but a handful of studies show little advantage over the base cream, and cosmetic doses run lower than research doses. Treat a Korean tranexamic acid serum as a gentle, slow, low-risk maintenance tool for melasma and recurring dark spots, lean on sunscreen, and give it a few months. For severe melasma, loop in a dermatologist rather than relying on a serum alone.

Frequently Asked Questions

Does topical tranexamic acid actually fade melasma?

Yes, but modestly and slowly. In a 100-person randomized trial, topical 5% tranexamic acid cut melasma severity about as much as 3% hydroquinone over 12 weeks, with fewer side effects. That said, some other trials found a tranexamic acid product worked no better than its base cream, so results are mixed. Expect gradual lightening over months, not a fast erase, and know that cosmetic serums often use lower concentrations than the studies.

Is a tranexamic acid serum as strong as the pill?

No. The oral pill has the strongest evidence — about 90% of patients improved in one large series — and meta-analyses rank oral as more effective than topical. A serum delivers far less drug to the melanocytes because the molecule struggles to penetrate intact skin. The trade-off is safety: a serum carries essentially no clotting risk, while the pill requires medical screening and is prescription-only.

Is tranexamic acid safe to put on your skin?

For most people, yes. Topical side effects are usually limited to mild irritation, dryness, or redness in a small minority of users, and trials show it's gentler than hydroquinone. The blood-clot concern people read about applies to the oral pill, not the serum, because almost none of a topical product reaches the bloodstream. Patch test first and pair it with sunscreen.

How long until a tranexamic acid serum works?

Plan on 8 to 12 weeks at a minimum, and often longer. Pigment turns over slowly, and one combination-serum study needed five months to show its full effect. Daily sunscreen is part of the deal — without it, ongoing sun exposure keeps triggering new pigment and cancels out the serum's work.

Tranexamic acid or niacinamide for dark spots?

They're partners more than rivals, which is why Korean serums usually combine them. Niacinamide is a broad, very gentle brightener that also supports the skin barrier and controls oil. Tranexamic acid is more targeted at melasma and recurring discoloration by acting on the pigment-signaling pathway. For melasma specifically, tranexamic acid (ideally alongside niacinamide) is the more pointed choice.

Medical Disclaimer

This article is for general information only and is not medical advice. Tranexamic acid for melasma is an off-label use; consult a qualified dermatologist or physician before starting any treatment, especially oral tranexamic acid, particularly if you have a history of blood clots or take hormonal medication.